Published Date: 13 Mar 2023
Among other things, international students seek connections and advice on how to better compete by supporting community groups.
Read Full NewsIn a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.
Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD
2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics
Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD
Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.
The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma
3.
FDA Approves Camizestrant for ESR1-Mutated Breast Cancer
4.
In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.
5.
A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.
1.
A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy
2.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
3.
Case Study: Genomic Medicine in Precision Oncology
4.
Cancer Enhancer Rewiring and Tumor Cell Identity
5.
Risk Assessment of Iron Overload in Repeated Transfusion
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
2.
Chemotherapy: What to Expect
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation